KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ·Healthcare·Biotechnology
$19.19
+0.16%
Mkt Cap $977.33M
Next Earnings
In 6 daysTue, May 5, 2026
EPS Estimate
-$0.41
5 analysts
Revenue Estimate
$38.34M
Last quarter: missed by -87.04% on EPS, -73.36% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$977.33M
P/E
—
Fwd P/E
—
P/S
13.02
Rev TTM
—
EPS TTM
-$3.20